Advancing Pulmonary Management in Cystic Fibrosis

Credit Area For Credit: Register/Login     View Activity As Guest

Release Date: Sep 20, 2013          Expiration Date: Sep 20, 2014



By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.



This program is part of a series of associated CME programs; Click Here for information.

Program Description


Dr. Katz describes the pulmonary damage that results from CFTR malfunction and the progress that has been made in preventing and delaying the resultant lung disease. Integration of new and emerging agents into current management protocols is also discussed.


Faculty


Marcia F. Katz, MD, FCCP
Associate Chair of Medicine for Clinical Affairs
The Brown Foundation Professor of Adult Cystic Fibrosis
Director, Adult Cystic Fibrosis Center
Associate Professor of Medicine
Head of Adult Medicine for the Texas Children’s Hospital Pavilion for Women
Baylor College of Medicine
Houston, TX

Read Biography


Target Audience


This activity is intended for pulmonary and gastrointestinal specialists who manage patients with CF.


Educational Objectives


At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Explain the importance of early determination of the specific mutation responsible for CF
  • Describe the current clinical trial evidence on new and emerging therapies aimed at improving and correcting CFTR function
  • Improve the identification of specific mutations and the individualization of therapy based on these mutations in people with CF
  • Incorporate the latest clinical data on new and emerging therapies to develop treatments aimed at optimizing the pulmonary and gastroenterological management of CF

Accreditation


This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Designation Statement


The Potomac Center for Medical Education designates this enduring activity for a maximum of 0.75 AMA PRA Category I credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding this activity, please email contact@rockpointe-pcme.com.


Disclosure Statement


Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

The faculty/steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Marcia F. Katz, MD FCCP: Advisory Board: Genentech, Gilead, Novartis; Speaker: Genentech, Gilead

Non-faculty Content Contributors:

Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Matthew Horn, MD; Blair St. Amand; Jay Katz; CCMEP: Nothing to Disclose


FDA Disclosure


The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.


System Requirements


In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can be downloaded here.

Instructions for Participants and Obtaining CME Credit


There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test and evaluation. To complete the evaluation online, choose the best answer to each question. The estimated time for completion of this activity is 45 minutes. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test.


Jointly Sponsored By


Potomac Center for Medical Education and Rockpointe

Co-provided by


Global Education Group

Supported By


Supported by an independent medical educational grant from Vertex Pharmaceuticals Incorporated


By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.